Correlation Between Kaleido Biosciences and Inhibikase Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kaleido Biosciences and Inhibikase Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kaleido Biosciences and Inhibikase Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kaleido Biosciences and Inhibikase Therapeutics, you can compare the effects of market volatilities on Kaleido Biosciences and Inhibikase Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kaleido Biosciences with a short position of Inhibikase Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kaleido Biosciences and Inhibikase Therapeutics.

Diversification Opportunities for Kaleido Biosciences and Inhibikase Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Kaleido and Inhibikase is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Kaleido Biosciences and Inhibikase Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibikase Therapeutics and Kaleido Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kaleido Biosciences are associated (or correlated) with Inhibikase Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibikase Therapeutics has no effect on the direction of Kaleido Biosciences i.e., Kaleido Biosciences and Inhibikase Therapeutics go up and down completely randomly.

Pair Corralation between Kaleido Biosciences and Inhibikase Therapeutics

If you would invest  348.00  in Inhibikase Therapeutics on January 12, 2025 and sell it today you would lose (141.00) from holding Inhibikase Therapeutics or give up 40.52% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Kaleido Biosciences  vs.  Inhibikase Therapeutics

 Performance 
       Timeline  
Kaleido Biosciences 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Kaleido Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental indicators, Kaleido Biosciences is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.
Inhibikase Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Inhibikase Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's forward-looking signals remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Kaleido Biosciences and Inhibikase Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kaleido Biosciences and Inhibikase Therapeutics

The main advantage of trading using opposite Kaleido Biosciences and Inhibikase Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kaleido Biosciences position performs unexpectedly, Inhibikase Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibikase Therapeutics will offset losses from the drop in Inhibikase Therapeutics' long position.
The idea behind Kaleido Biosciences and Inhibikase Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets